Latest Period
Q1 2026
Security Snapshot
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) Institutional Ownership
CUSIP: 76155X118
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
21
Shares (Excl. Options)
10,046,740
Price
$1.79
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / *W EXP 12/17/202
- Symbol
- RVMDW on Nasdaq
- Price per share
- $5.48
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 10,046,740
- Total reported value
- $17,825,175
- % of total 13F portfolios
- 0%
- Share change
- +1,348,510
- Value change
- +$2,736,012
- Number of holders
- 21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 is tracked under CUSIP 76155X118.
- 21 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 22 to 21 between Q4 2025 and Q1 2026.
- Reported value moved from $8,150,297 to $17,825,175.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 21 institutions filings for Q1 2026.
Security key
76155X118
Latest holder period
Q1 2026
13F holders
21
13D/G owners
0
CIK / CUSIP context first
Open Q1 2026 holders
RVMDW full holder history
Revolution Medicines, Inc. SEC filings
Revolution Medicines, Inc. company facts
Revolution Medicines, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 76155X118:
As of 31 Mar 2026, 21 institutional investors reported holding 10,046,740 shares of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW).
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 10,046,740 | $17,825,175 | +$2,736,012 | $1.79 | 21 |
| 2025 Q4 | 8,698,230 | $8,150,297 | +$712,708 | $0.94 | 22 |
| 2025 Q3 | 8,066,230 | $2,455,615 | +$3,514 | $0.30 | 21 |
| 2025 Q2 | 8,041,860 | $2,116,552 | +$143,332 | $0.26 | 21 |
| 2025 Q1 | 7,647,321 | $298,455 | -$13,607 | $0.04 | 22 |
| 2024 Q4 | 7,607,269 | $1,314,887 | +$528,254 | $0.18 | 20 |
| 2024 Q3 | 4,670,066 | $654,653 | -$223,218 | $0.14 | 21 |
| 2024 Q2 | 4,415,864 | $449,673 | -$2,591 | $0.10 | 14 |
| 2024 Q1 | 6,884,843 | $1,210,097 | +$360,139 | $0.18 | 21 |
| 2023 Q4 | 4,907,148 | $1,621,737 | +$1,596,327 | $0.33 | 19 |